Molecular Partners executives will speak at two investor conferences focusing on their DARPin therapeutics

From GlobeNewswire: 2025-05-19 01:00:00

Molecular Partners AG announced that members of the management team will participate in two upcoming investor conferences. The H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ will have a fireside chat on May 20, 2025 at 3:30pm ET, while TD Cowen’s 6th Annual Oncology Innovation Summit will feature a fireside chat on May 28, 2025 at 10:00am ET. Both events will be webcast and available on the Molecular Partners website. The company focuses on developing DARPin therapeutics for medical challenges, with oncology as its main focus. For more information, visit www.molecularpartners.com.



Read more at GlobeNewswire: Molecular Partners to Present at Upcoming Investor